Cancer Therapeutics
Murex Pharmaceuticals Licenses Ariadnes Pathway Studio Software Solution To Be Utilized For Cancer Therapeutics Development – July 27, 2006 Ariadne Genomics, Inc. today announced that Murex Pharmaceuticals (Dallas, Texas) has licensed its Pathway Studio® software solution for the visualization and … Continued